Paper392087
Recent developments concerning muramyl dipeptide, a synthetic immunoregulating molecule.
Chedid L and 2 others. J Reticuloendothel Soc, 1979. Cited by 62 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Recent developments concerning muramyl dipeptide, a synthetic immunoregulating molecule. Papers, record 392087. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/392087
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acetylmuramyl-Alanyl-Isoglutamine | Major topic |
| Adjuvants, Immunologic | Major topic |
| Antibody Formation | Major topic |
| Glycopeptides | Major topic |
| Immunity, Cellular | Major topic |
| Animals | |
| Antigens | |
| Chemical Phenomena | |
| Chemistry | |
| Fever | |
| Liposomes | |
| Structure-Activity Relationship |
Source PubMed
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 62 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 21299227 | Structure-activity relationships in nucleotide oligomerization domain 1 (Nod1) agonistic γ-glutamyldiaminopimelic acid derivatives. | J Med Chem | 2011 | https://conductscience.org/library/papers/21299227 | PubMed |
| 17422948 | Adjuvants et stimulants de l'immunité: propriétés immunorégulatrices du muramyl-dipeptide, des corynébactéries anaérobies et du diéthyldithiocarbamate de sodium. | Can Vet J | 1988 | https://conductscience.org/library/papers/17422948 | PubMed |
| 7035868 | Muramyl peptides. Chemical structure, biological activity and mechanism of action. | Mol Cell Biochem | 1981 | https://conductscience.org/library/papers/7035868 | PubMed |
| 6940181 | Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide. | Proc Natl Acad Sci U S A | 1981 | https://conductscience.org/library/papers/6940181 | PubMed |
| 6777304 | Comparison of muramyl dipeptide, trehalose dimycolate, and dimethyl dioctadecyl ammonium bromide as adjuvants in Brucella abortus 45/20 vaccines. | Infect Immun | 1980 | https://conductscience.org/library/papers/6777304 | PubMed |
| 6608216 | Anti-inflammatory effects of muramyl dipeptide in experimental models of acute inflammation. | Agents Actions | 1984 | https://conductscience.org/library/papers/6608216 | PubMed |
| 6566601 | Muramyl dipeptide is a powerful potentiator of the antitumor action of various tumor-necrotizing agents. | Cancer Immunol Immunother | 1984 | https://conductscience.org/library/papers/6566601 | PubMed |
| 6365745 | Stimulation of macrophage protease secretion via liposomal delivery of muramyl dipeptide derivatives to intracellular sites. | Immunology | 1984 | https://conductscience.org/library/papers/6365745 | PubMed |
| 6352008 | Macrophages in cancer metastases and their relevance to metastatic growth. | Cancer Metastasis Rev | 1983 | https://conductscience.org/library/papers/6352008 | PubMed |
| 6284643 | In vivo induction of anti-herpes simplex virus immune response by type 1 antigens and lipid A incorporated into liposomes. | Infect Immun | 1982 | https://conductscience.org/library/papers/6284643 | PubMed |
| 3876287 | Degradation of muramyl dipeptide by mammalian serum. | Infect Immun | 1985 | https://conductscience.org/library/papers/3876287 | PubMed |
| 3867329 | Prevention of oncogenic viral infections in mice with CGP 11637, a synthetic muramyl dipeptide analog. | Antimicrob Agents Chemother | 1985 | https://conductscience.org/library/papers/3867329 | PubMed |
| 3396025 | In vitro activation of tumoricidal properties in mouse macrophages using the chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine (FMLP) incorporated in liposomes. | Cancer Immunol Immunother | 1988 | https://conductscience.org/library/papers/3396025 | PubMed |
| 3302929 | Liposomes in treatment of infectious diseases. | Pharm Weekbl Sci | 1987 | https://conductscience.org/library/papers/3302929 | PubMed |
| 3244663 | Formulation of vaccine adjuvant muramyldipeptides (MDP). 2. The thermal reactivity and pH of maximum stability of MDP compounds in aqueous solution. | Pharm Res | 1988 | https://conductscience.org/library/papers/3244663 | PubMed |
| 1997424 | Rapid elimination of a synthetic adjuvant peptide from the circulation after systemic administration and absence of detectable natural muramyl peptides in normal serum at current analytical limits. | Infect Immun | 1991 | https://conductscience.org/library/papers/1997424 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/392087
GET https://conductscience.org/api/papers/v1/392087/authors